We are proud to present to you during this World Congres of Thyroid Cancer the FLUOBEAM®, which is able to identify parathyroid glands by autofluorescence but also their perfusion, real bonus and gain in the prevention of the post-operative complications. Come to discover or to rediscover with our application engineers the various applications of the FLUOBEAM® on the booth 12.
As every year the meeting is divided in three days. There will be much discussion on hot topics and trends in areas of Endocrine surgery, the papillary thyroid cancer, the quality approach in thyroid surgery. It is with great delight and motivation that our team will be presented during all this congress. We would be pleased to exchange with you about on the available applications of our new device, the FLUOBEAM® LX on our stand.
FLUOPTICS© is a French company which develops innovative solutions of imaging by fluorescence to guide in real time the surgeon during the operative act.This year FLUOPTICS© will be present to propose you our new device,the FLUOBEAM® LX system, which is dedicated to thyroid and parathyroid surgery. This device is the only one on the market to propose an application allowing to visualize parathyroid glands by autofluorecence and their perfusion. Our application engineers wait for you on our booth to exchange with you in more detail.
Main association of endocrine surgery in North America, the American Association of Endocrine Surgeons organizes his 39th congress in Los Angeles. As every year FLUOPTICS© will be present to propose you our device, FLUOBEAM®. This device is the only one on the market to propose an application allowing to visualize parathyroid glands by autofluorecence and their perfusion. Our application engineers wait for you on our booth to exchange with you in more detail.
Thyroid and parathyroid surgery are two common surgical procedures that have become very safe thanks to the surgical advances. However, hypoparathyroidism remains the current concern of thyroid surgery.
New fluorescence imagining techniques, have been developed to help the detection of parathyroid glands and confirm their vascularization. This has opened a new exciting area of research for surgeons and scientists.
Moreover, our fluorescence imagining system FLUOEAM® has received the market authorization from FDA to help in real-time localization of parathyroid tissue during procedures such as thyroidectomy or parathyroidectomy.
In this context, we are delighted to see you at this first international symposium and to present to you our fluorescence imaging solutions and their various applications.
We also invite you to our symposium presented by Mrs. Odile ALLARD the CEO of Fluoptics© and Mr. Philippe RIZO the CTO of Fluoptics©, which is based on the latest Fluoptics© innovations. This symposium will take place on February 28th from 6 to 7 pm.
The 20th world congress of Senologic International Society on healthcare will take place in Strasbourg this year. It will focus on current challenges on breast cancer and what future research still has to achieve. Leading specialists from around the world will approach various subjects focused on the patient and their diseases. The scientific sessions will be on prevention, screening, diagnosis and treatment of breast cancer.
Our team will be at this event in order to present to you our medical device, FLUOBEAM®, and all its latest applications which can help in fluorescence surgery.
As every year, the surgical association of endocrinology, CAEK, gathered to exchange on various themes of the endocrinology, the scientific discoveries in molecular biology and the cooperation between different medical specialization. This 37th congress will study the current results of endocrine surgery theses and also on the clinical and scientific questions of the patient prognosis and his quality of life for thyroid surgery, the parathyroid glands, adrenal and pancreatic.
For this congress we shall be delighted to meet you on our booth to present to you our FLUOBEAM® that you could test. Be the first to discover our latest application dedicated to the thyroid and parathyroid glands surgery.
The DAM Microchirurgie will take place in the lovely city of Lugano, in Switzerland. For this occasion, this congress will focus on various domains such as searches and innovations in microsurgery. Once again, this year groups of experts will regroup to develop some recommendations on the different themes and animated working group on microsurgery problems.
Involved in this dynamic evolution, Fluoptics© has the pleasure to take part to this event. Do not hesitate to visit us at our booth and discover our medical device, FLUOBEAM®, and be the first to test our latest applications which help in microsurgery.